Division of Spine, Department of Orthopaedics, Tongji Hospital, Tongji University School of Medicine, 200065, Shanghai, China.
Key Laboratory of Spine and Spinal cord Injury Repair and Regeneration (Tongji University), Ministry of Education, 200065, Shanghai, China.
Signal Transduct Target Ther. 2023 Jun 26;8(1):245. doi: 10.1038/s41392-023-01477-6.
Spinal cord injury (SCI) remains a severe condition with an extremely high disability rate. The challenges of SCI repair include its complex pathological mechanisms and the difficulties of neural regeneration in the central nervous system. In the past few decades, researchers have attempted to completely elucidate the pathological mechanism of SCI and identify effective strategies to promote axon regeneration and neural circuit remodeling, but the results have not been ideal. Recently, new pathological mechanisms of SCI, especially the interactions between immune and neural cell responses, have been revealed by single-cell sequencing and spatial transcriptome analysis. With the development of bioactive materials and stem cells, more attention has been focused on forming intermediate neural networks to promote neural regeneration and neural circuit reconstruction than on promoting axonal regeneration in the corticospinal tract. Furthermore, technologies to control physical parameters such as electricity, magnetism and ultrasound have been constantly innovated and applied in neural cell fate regulation. Among these advanced novel strategies and technologies, stem cell therapy, biomaterial transplantation, and electromagnetic stimulation have entered into the stage of clinical trials, and some of them have already been applied in clinical treatment. In this review, we outline the overall epidemiology and pathophysiology of SCI, expound on the latest research progress related to neural regeneration and circuit reconstruction in detail, and propose future directions for SCI repair and clinical applications.
脊髓损伤(SCI)仍然是一种严重的疾病,致残率极高。SCI 修复面临的挑战包括其复杂的病理机制和中枢神经系统神经再生的困难。在过去的几十年中,研究人员试图彻底阐明 SCI 的病理机制,并确定有效的策略来促进轴突再生和神经回路重塑,但结果并不理想。最近,通过单细胞测序和空间转录组分析,揭示了 SCI 的新病理机制,特别是免疫和神经细胞反应之间的相互作用。随着生物活性材料和干细胞的发展,人们越来越关注形成中间神经网络以促进神经再生和神经回路重建,而不是促进皮质脊髓束中的轴突再生。此外,用于控制电、磁和超声等物理参数的技术不断创新并应用于神经细胞命运调控。在这些先进的新策略和技术中,干细胞治疗、生物材料移植和电磁刺激已进入临床试验阶段,其中一些已应用于临床治疗。在这篇综述中,我们概述了 SCI 的总体流行病学和病理生理学,详细阐述了神经再生和回路重建的最新研究进展,并提出了 SCI 修复和临床应用的未来方向。